Cargando…
A Review of Hyperglycemia in COVID-19
Diabetes mellitus (DM) is one of the most common chronic metabolic disorders worldwide, which increases the risk of common and opportunistic infections. Following the coronavirus disease 2019 (COVID-19) pandemic, a higher incidence rate, more severe forms of the disease, and exacerbation of hypergly...
Autores principales: | Zahedi, Maryam, Kordrostami, Saba, Kalantarhormozi, Mohammadreza, Bagheri, Marziyeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181889/ https://www.ncbi.nlm.nih.gov/pubmed/37187644 http://dx.doi.org/10.7759/cureus.37487 |
Ejemplares similares
-
Hyperglycemia in Severe and Critical COVID-19 Patients: Risk Factors and Outcomes
por: Le, Viet Tran, et al.
Publicado: (2022) -
A Sweet Paradox: Severe Insulin Resistance and Hyperglycemia in Asymptomatic COVID-19 Infection
por: Ramchandani, Bhanvi P, et al.
Publicado: (2023) -
Hemichorea-Hemiballism as a Manifestation of Hyperglycemia
por: Maia, Maria, et al.
Publicado: (2021) -
Stress-Induced Hyperglycemia: Consequences and Management
por: Vedantam, Deepanjali, et al.
Publicado: (2022) -
THU319 Hyperglycemia Associated With Raynaud’s Phenomenon And Liver Dysfunction After COVID-19 Vaccination In Type 1 Diabetes
por: Zavgorodneva, Zhanna, et al.
Publicado: (2023)